Targeting HSP70 for Cancer Therapy

Lorenzo Galluzzi; Fabrizio Giordanetto; Guido Kroemer

doi:10.1016/j.molcel.2009.10.003

Targeting HSP70 for Cancer Therapy

Lorenzo Galluzzi, Fabrizio Giordanetto, Guido Kroemer

Research output: Contribution to journal › Short survey › peer-review

44 Scopus citations

Abstract

In a recent issue of Molecular Cell, Leu et al. (2009) demonstrate that a chemical inhibitor of HSP70 exerts prominent tumor-selective cytotoxic effects, thereby lending further support to the notion that non-oncogene addiction constitutes a promising target for anticancer therapy.

Original language	English
Pages (from-to)	176-177
Number of pages	2
Journal	Molecular Cell
Volume	36
Issue number	2
DOIs	https://doi.org/10.1016/j.molcel.2009.10.003
State	Published - Oct 23 2009
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.molcel.2009.10.003

Cite this

@article{41e0c11c438744a5a45f1f5908bd43d4,

title = "Targeting HSP70 for Cancer Therapy",

abstract = "In a recent issue of Molecular Cell, Leu et al. (2009) demonstrate that a chemical inhibitor of HSP70 exerts prominent tumor-selective cytotoxic effects, thereby lending further support to the notion that non-oncogene addiction constitutes a promising target for anticancer therapy.",

author = "Lorenzo Galluzzi and Fabrizio Giordanetto and Guido Kroemer",

year = "2009",

month = oct,

day = "23",

doi = "10.1016/j.molcel.2009.10.003",

language = "English",

volume = "36",

pages = "176--177",

journal = "Molecular Cell",

issn = "1097-2765",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - Targeting HSP70 for Cancer Therapy

AU - Galluzzi, Lorenzo

AU - Giordanetto, Fabrizio

AU - Kroemer, Guido

PY - 2009/10/23

Y1 - 2009/10/23

N2 - In a recent issue of Molecular Cell, Leu et al. (2009) demonstrate that a chemical inhibitor of HSP70 exerts prominent tumor-selective cytotoxic effects, thereby lending further support to the notion that non-oncogene addiction constitutes a promising target for anticancer therapy.

AB - In a recent issue of Molecular Cell, Leu et al. (2009) demonstrate that a chemical inhibitor of HSP70 exerts prominent tumor-selective cytotoxic effects, thereby lending further support to the notion that non-oncogene addiction constitutes a promising target for anticancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=70350120030&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2009.10.003

DO - 10.1016/j.molcel.2009.10.003

M3 - Short survey

C2 - 19854128

AN - SCOPUS:70350120030

SN - 1097-2765

VL - 36

SP - 176

EP - 177

JO - Molecular Cell

JF - Molecular Cell

IS - 2

ER -

Targeting HSP70 for Cancer Therapy

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this